TABLE 2.
Abnormal laboratory results for COVID‐2019 and CAP patients
| Variable | COVID‐2019 (n = 84) | CAP (n = 221) | P |
|---|---|---|---|
| WBC | .00 | ||
| Normal | 55 (65.5%) | 118 (53.4%) | |
| Low | 20 (23.8%) | 27 (12.2%) | |
| High | 9 (10.7%) | 76 (34.4%) | |
| RBC | .00 | ||
| Normal | 51 (60.7%) | 36 (16.3%) | |
| Low | 33 (39.3%) | 185 (83.7%) | |
| HGB | .00 | ||
| Normal | 55 (65.5%) | 36 (16.2%) | |
| Low | 29 (34.5%) | 185 (83.7%) | |
| PLT | .01 | ||
| Normal | 59 (70.2%) | 135 (61.1%) | |
| Low | 25 (29.8%) | 65 (29.4%) | |
| High | 0 (0%) | 21 (9.5%) | |
| NEU | .00 | ||
| Normal | 62 (73.8%) | 104 (47.1%) | |
| Low | 9 (10.7%) | 25 (11.3%) | |
| High | 13 (15.5%) | 92 (41.6%) | |
| LYM | .00 | ||
| Normal | 15 (17.9%) | 93 (42.1%) | |
| Low | 68 (81.0%) | 125 (56.6%) | |
| High | 1 (1.2%) | 3 (1.4%) | |
| MONO | .00 | ||
| Normal | 73 (86.9%) | 111 (50.2%) | |
| Low | 1 (1.2%) | 13 (5.9%) | |
| High | 10 (11.9%) | 97 (43.9%) | |
| EO | .00 | ||
| Normal | 19 (22.6%) | 145 (65.6%) | |
| Low | 65 (77.4%) | 70 (31.7%) | |
| High | 0 (0%) | 6 (2.7%) | |
| BASO | .00 | ||
| Normal | 84 (100%) | 177 (80.1%) | |
| High | 0 (0%) | 44 (19.9%) | |
| HCT | .00 | ||
| Normal | 46 (54.8%) | 31 (14.0%) | |
| Low | 38 (45.2%) | 190 (86.0%) | |
| MCV | .34 | ||
| Normal | 75 (89.3%) | 188 (85.1%) | |
| Low | 5 (6.0%) | 11 (5.0%) | |
| High | 4 (4.8%) | 22 (10.0%) | |
| MCH | .96 | ||
| Normal | 72 (85.7%) | 192 (86.9%) | |
| Low | 6 (7.1%) | 15 (6.8%) | |
| High | 6 (7.1%) | 14 (6.3%) | |
| MCHC | .00 | ||
| Normal | 73 (86.9%) | 197 (89.1%) | |
| Low | 0 (0%) | 24 (10.9%) | |
| High | 11 (13.1%) | 0 (0) | |
| RDW | .00 | ||
| Normal | 81 (96.4%) | 156 (70.6%) | |
| High | 3 (3.6%) | 65 (29.4%) | |
| MPV | .36 | ||
| Normal | 81 (96.4%) | 217 (98.2%) | |
| High | 3 (3.6%) | 4 (1.8%) | |
| ALT | .28 | ||
| Normal | 65 (77.4%) | 183 (82.8%) | |
| High | 19 (22.6%) | 38 (17.2%) | |
| AST | .00 | ||
| Normal | 52 (61.9%) | 178 (80.5%) | |
| High | 32 (38.1%) | 43 (19.5%) | |
| TBIL | .02 | ||
| Normal | 81 (96.4%) | 194 (87.8%) | |
| High | 3 (3.6%) | 27 (12.2%) | |
| DBIL | .89 | ||
| Normal | 72 (85.7%) | 188 (85.1%) | |
| High | 12 (14.3%) | 33 (14.9%) | |
| UBIL | .02 | ||
| Normal | 82 (97.6%) | 195 (88.2%) | |
| High | 2 (2.4%) | 23 (10.4%) | |
| TP | .00 | ||
| Normal | 65 (77.4%) | 106 (48.0%) | |
| Low | 19 (22.6%) | 115 (52.0%) | |
| ALB | .00 | ||
| Normal | 50 (59.5%) | 36 (16.3%) | |
| Low | 34 (40.5%) | 185 (83.7%) | |
| GLB | .00 | ||
| Normal | 62 (73.8%) | 109 (49.3%) | |
| Low | 1 (1.2%) | 20 (9.0%) | |
| High | 21 (25%) | 92 (41.6%) | |
| GGT | .83 | ||
| Normal | 59 (70.2%) | 158 (71.5%) | |
| High | 25 (29.8%) | 63 (28.5%) | |
| ALP | .01 | ||
| Normal | 77 (91.7%) | 175 (79.2%) | |
| High | 7 (8.3%) | 46 (20.8%) | |
| TBA | .37 | ||
| Normal | 80 (95.2%) | 204 (92.3%) | |
| High | 4 (4.8%) | 17 (7.7%) | |
| PCT | .00 | ||
| Normal | 44 (52.4%) | 55 (24.9%) | |
| High | 40 (47.6%) | 164 (74.2%) | |
| CRP | .00 | ||
| Normal | 7 (8.3%) | 38 (17.2%) | |
| High | 64 (76.2%) | 104 (47.1%) |